A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension”, The Journal of Heart and Lung Transplantation , October 4, 2024: a state-of-the-art review which summarizes the current understanding of the mechanism of action of sotatercept, the impact on outcomes that improve how patients feel, function, and survive, and the safety and adverse event profile to inform readers of this novel therapy.
Citation
A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension, Thomas M. Cascino, MD, MSc, Sandeep Sahay, MSc,∙ Victor M. Moles, MD, Vallerie V. McLaughlin, MD, The Journal of Heart and Lung Transplantation, Volume 0, Issue 0, DOI: 10.1016/j.healun.2024.09.021
Read more at the link on the Journal of Heart and Lung Transplantation